Medtronic received FDA approval for its Valiant Navion thoracic stent graft, a minimally invasive system for correction of lesions within the descending thoracic aorta, particularly in patients with narrow iliac arteries. The device is indicated in thoracic aortic aneurysms (TAA), blunt thoracic aortic injuries, penetrating atherosclerotic ulcers, intramural hematomas, and aortic type B dissections. Patients with […]
Month: October 2018
Branch Retinal Vein Occlusion | BRVO
Branch retinal vein occlusion is a more common type of retinal vascular occlusion. Treatment options are usually very successful in regaining vision.
The post Branch Retinal Vein Occlusion | BRVO appeared first on Retina Specialist | Fairfax, Virgini…
MC2 Therapeutics meldet Topline-Ergebnisse mit positivem Sicherheitsprofil und Reduzierung der kornealen Anfärbungen durch MC2-03 bei Patienten mit Trockenem Auge und mittlerer bis schwerer Keratitis
KOPENHAGEN, Dänemark–(BUSINESS WIRE)–MC2 Therapeutics A/S, ein Hersteller von Medikamenten für Haut- und Augenkrankheiten, gab heute Topline-Ergebnisse der Phase-2-Studie „MC2-03-C1 Northern Lights“ zur Sicherheit und Wirksamkeit von MC2-03 (PADciclo…
MC2 Therapeutics maakt toplijnresultaten bekend waaruit een gunstig veiligheidsprofiel en vermindering van corneale kleuring blijkt voor MC2-03 bij droge ogenpatiënten met matige tot ernstige keratitis
KOPENHAGEN, Denemarken–(BUSINESS WIRE)–MC2 Therapeutics A/S, een dermatologie- en oogzorgbedrijf in de klinische fase, heeft vandaag de toplijnresultaten van de MC2-03-C1 Northern Light Fase 2-studie bekendgemaakt, waarbij de veiligheid en werkzaamhe…
MC2 Therapeutics annonce des résultats exceptionnels : profil d’innocuité favorable des gouttes MC2-03 qui permettent une réduction de la souillure cornéenne chez les patients atteints de kératite modérée à sévère…
COPENHAGUE, Danemark–(BUSINESS WIRE)–MC2 Therapeutics annonce des résultats exceptionnels : profil d’innocuité favorable des gouttes MC2-03 qui permettent une réduction de la souillure cornéenne chez les patients atteints de kératite modérée à sévère…
Carl Zeiss Meditec acquires miLOOP developer IanTECH
Carl Zeiss Meditec will acquire IanTECH, the developer of the miLOOP lens fragmentation device, expanding its cataract surgery portfolio, the company announced in a press release.“We expect that IanTECH will complement our leading portfolio of equipmen…
MC2 Therapeutics annuncia risultati topline a dimostrazione del profilo favorevole di sicurezza e della riduzione nello staining corneale di MC2-03 nei pazienti con secchezza oculare con cheratite da moderata a grave
COPENAGHEN, Danimarca–(BUSINESS WIRE)–MC2 Therapeutics A/S, società di stadio clinico specializzata in dermatologia e oculistica, ha oggi annunciato i risultati topline dello studio di fase 2 MC2-03-C1 Northern Lights per la valutazione della sicurez…
HeartMate 3 Heart Pump Approved for Patients Not Eligible for Transplant
Abbott‘s HeartMate 3 left ventricular assist device (LVAD) won FDA approval to be used as a destination therapy for advanced heart failure patients who are not eligible for a transplant. Previously, the device has been indicated for patients eligible for and waiting for a transplant. Since transplant hearts are rarely available and not all patients […]
IDx, Topcon sign agreement about AI diagnostic system
IDx reached an exclusivity agreement with Topcon to sell its artificial intelligence-based diagnostic system with the Topcon NW400 robotic fundus camera.The agreement grants exclusive rights to IDx in the United States as the only autonomous AI company…
OcuSciences Announces Publication Showing OcuMet Beacon Retinal Imager May Detect Glaucoma Earlier Than Current Standard Measures and Be Useful in Assessing Disease Severity
ANN ARBOR, Mich.–(BUSINESS WIRE)–OcuSciences, Inc., a clinical-stage biotechnology company developing retinal imagers to detect early disease by assessing retinal metabolic activity, today announced the online publication of its initial glaucoma stud…
Earnin Survey Shows Majority of Americans Are Delaying Medical Care
PALO ALTO, Calif.–(BUSINESS WIRE)–#earnin–Earnin, an app that allows anyone with a job and a bank account to get paid the minute they leave work, today released the results from a pair of September 2018 surveys. One was conducted online among over 2…
Cell Care Therapeutics Raises $4.3 Million in Seed Funding
MONROVIA, Calif.–(BUSINESS WIRE)–#diabeticretinopathy–Cell Care Therapeutics raises $4.3 million seed funding to develop preclinical-stage drug candidate for the treatment of ocular inflammatory diseases.
VIDEO: The Ocular Surface: Critical for Refractive Cataract Surgery Success
NEW YORK — From OSN New York 2018, Darrell White, MD, founder of SkyVision Centers in Westlake, Ohio, gives his presentation on how the ocular surface is critical for refractive cataract surgery success.
Ophthotech Corporation to Report Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, October 31, 2018
NEW YORK–(BUSINESS WIRE)–Ophthotech today announced that it will report its third quarter 2018 financial and operating results on Wednesday, October 31, 2018.
Aerie Pharmaceuticals Establishes GMP PRINT® Production Facility in an Expanded Global Headquarters
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
MC2 Therapeutics Announces Topline Results Showing a Favorable Safety Profile and Reduction in Corneal Staining for MC2-03 in Dry Eye Patients with Moderate to Severe Keratitis
COPENHAGEN, Denmark–(BUSINESS WIRE)–MC2 Therapeutics A/S, a clinical-stage dermatology and eye care company, today announced topline results from the MC2-03-C1 Northern Lights Phase 2 trial evaluating the safety and efficacy of MC2-03 (PADciclo™) in …
Santen initiates phase 3 trials of omidenepag isopropyl for glaucoma, ocular hypertension
A pivotal phase 3 development program of omidenepag isopropyl for the treatment of glaucoma or ocular hypertension has been initiated by Santen Inc., the company announced in a press release.The SPECTRUM 3 and SPECTRUM 4 trials, both randomized, double…
AireSone Junior Wearable Respiratory Monitor For Children: Interview with Adrian Ang, CEO AEvice Health
AireSone Junior is a wearable respiratory monitor for children that has been developed by AEvice Health, a spinout of Nanyang Technological University in Singapore. The device is attached to a child’s chest at night and listens to their breathing. An algorithm can process the audio signal, measuring the respiratory rate, heart rate, and sleep cycle, […]
Magnetically Operated Surgical Tool Cleared for Weight Loss Operations
Levita Magnetics, a Silicon Valley firm, won FDA clearance to introduce its Levita Magnetic Surgical System for use in bariatric procedures. Previously, the magnetically controlled surgical device has only had clearance in the U.S. for performing cholecystectomies (gallbladder removal). The system consists of a small metallic clasping tool that is placed within the treatment area […]
VIDEO: Surface Ablation: Pearls and Pitfalls
NEW YORK — From OSN New York 2018, Parag A. Majmudar, MD, associate professor of ophthalmology at Rush University Medical Center and cornea and refractive specialist at Chicago Cornea Consultants, gives his presentation on surface ablation pearls and p…